SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Incyte (INCY)
INCY 102.05+0.3%Nov 21 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RCMac who wrote (925)3/22/1999 2:24:00 AM
From: A.J. Mullen  Read Replies (1) of 3202
 
RCM,
Yes, very useful reminder that royalties stemming from use of software independent of patents. My concern wrt patentability is whether the courts might hold that, for a patent to be valid, there must be some description of the function. What's going to happen when a team that has elucidated the gene & defect responsible for a disease discovers INCYTE has already patented a piece of DNA that intersects "their" gene? I would imagine they would argue that they've done the useful science, and they should get the rewards.

RCM, would you address the issue please? Despite this concern I own INCYTE, and recently bought more.

AJ
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News